Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioPacific Ventures is a specialist venture capital firm based in Auckland, New Zealand, primarily focused on investments in the life sciences, food, and agriculture sectors. Established in 2005, the firm was launched as a $150 million (NZD) fund managed by a partnership between Direct Capital and BioPacific Partners. It specifically targets early-stage companies across Australia and New Zealand that demonstrate potential for global scale, particularly in health, wellness, and sustainable nutrition. The fund's notable cornerstone investors include the multinational food company Nestlé and the New Zealand government’s AgResearch agency. BioPacific Ventures leverages its deep industry connections to provide strategic support and bridge the gap between regional scientific research and global commercial markets. Throughout its tenure, the firm has maintained a portfolio including companies in medical technology, drug discovery, and functional foods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioPacific Ventures.